Northeast Financial Consultants Inc Gilead Sciences, Inc. Transaction History

Northeast Financial Consultants Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 30, 2020	SELL	$72.34 - $84.0 $259,700 - $301,560	-3,590 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $4,509 - $5,775	72 Added 2.05%	3,590 $268,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $11,892 - $13,081	193 Added 5.8%	3,518 $229,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $3,188 - $3,519	51 Added 1.56%	3,325 $211,000
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $202,562 - $227,150	3,274 New	3,274 $221,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.